NNNNVSSLS• 6 Months (Normalized)
NNNN vs SLS (Anbio Biotechnology vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NNNN Performance $6.34
-70.94%
Anbio Biotechnology
Normalized Baseline0.00%
SLS Performance $11.55
+115.49%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin SLS LEADS
-186.43%
SLS outperforming by 186.43%
NNNNSLS
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NNNN SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | NNNN Price | NNNN Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $6.34 | -70.94% | $11.55 | +115.49% | -186.43% |
| Sep 10, 2026 | $6.51 | -70.16% | $13.49 | +151.68% | -221.84% |
| Sep 09, 2026 | $6.47 | -70.35% | $13.95 | +160.26% | -230.61% |
| Sep 08, 2026 | $6.48 | -70.30% | $13.96 | +160.45% | -230.75% |
| Sep 04, 2026 | $6.54 | -70.03% | $13.86 | +158.58% | -228.61% |
| Sep 03, 2026 | $6.60 | -69.75% | $13.70 | +155.60% | -225.35% |
| Sep 02, 2026 | $6.85 | -68.61% | $14.16 | +164.18% | -232.79% |
| Sep 01, 2026 | $7.22 | -66.91% | $13.22 | +146.64% | -213.55% |
| Aug 31, 2026 | $7.30 | -66.54% | $13.34 | +148.88% | -215.42% |
| Aug 28, 2026 | $7.67 | -64.85% | $13.21 | +146.46% | -211.31% |
| Aug 27, 2026 | $7.78 | -64.34% | $15.21 | +183.77% | -248.11% |
| Aug 26, 2026 | $7.72 | -64.62% | $13.73 | +156.16% | -220.78% |
| Aug 25, 2026 | $7.83 | -64.12% | $14.09 | +162.87% | -226.99% |
| Aug 24, 2026 | $7.90 | -63.79% | $14.33 | +167.35% | -231.14% |
| Aug 21, 2026 | $6.81 | -68.79% | $15.46 | +188.43% | -257.22% |
Page 1 of 9